|
|
|
Insider
Information: |
Lanfear Dennis M |
Relationship: |
|
City: |
Richmond |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
877,098 |
|
Indirect Shares
|
519,649 |
|
|
Direct
Value |
$11,962,077 |
|
|
Indirect Value
|
$878,207 |
|
|
Total
Shares |
1,396,747 |
|
|
Total
Value |
$12,840,283 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-25.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Insmed Inc |
INSM |
Director |
2010-06-09 |
168,404 |
2009-03-31 |
0 |
Premium* |
|
Coherus Biosciences, Inc. |
CHRS |
|
2024-01-20 |
708,694 |
2024-01-20 |
519,649 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CHRS |
Coherus Biosciences, Inc. |
President & CEO |
|
2024-01-04 |
4 |
D |
$2.92 |
$34,401 |
D/D |
(11,781) |
719,912 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
President & CEO |
|
2023-11-22 |
4 |
S |
$2.02 |
$449,770 |
D/D |
(223,100) |
731,693 |
0 |
% |
|
CHRS |
Coherus Biosciences, Inc. |
President & CEO |
|
2023-11-22 |
4 |
OE |
$1.42 |
$425,015 |
D/D |
299,940 |
954,793 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
President & CEO |
|
2019-05-30 |
4 |
S |
$19.49 |
$631,282 |
I/I |
(32,398) |
1,284,184 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
See Remarks |
|
2018-05-16 |
4 |
S |
$16.26 |
$341,265 |
I/I |
(20,984) |
1,316,582 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
President and CEO |
|
2016-09-21 |
4 |
AS |
$31.75 |
$1,588 |
I/I |
(50) |
1,337,566 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
President and CEO |
|
2016-09-20 |
4 |
AS |
$31.75 |
$127,322 |
I/I |
(4,010) |
1,337,616 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
President and CEO |
|
2016-09-16 |
4 |
AS |
$31.79 |
$92,199 |
I/I |
(2,900) |
1,341,626 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
See Remarks |
|
2014-12-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
20,000 |
1,341,921 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
President and CEO |
|
2015-11-30 |
4 |
AS |
$31.75 |
$12,700 |
I/I |
(400) |
1,344,526 |
0 |
- |
|
CHRS |
Coherus Biosciences, Inc. |
See RemarksOfficer |
|
2014-11-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,358,728 |
|
- |
|
36 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|